Modeling savings from prophylactic REACT antioxidant use among a cohort initially aged 50-55 years: A canadian perspective

Journal of Orthomolecular Medicine

Volumn 21, Issue 4, 2006, Pages 212-220

  Trevithick, John R ^a   Massel, David ^a   Robertson, James McD ^a   Wall, Ronald ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Cataract; Cost savings; Economic effects; Oxidative stress; Present value; REACT; Risk reduction; Vitamins E, C, and carotene

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE;

ADULT; AGED; ARTICLE; CANADA; CATARACT; CATARACT EXTRACTION; CONTROLLED STUDY; COST CONTROL; DRUG COST; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK REDUCTION;

EID: 33846187716     PISSN: 03170209     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Meydani M: Vitamin E. Lancet, 1995; 345: 170-75.
2. Robertson JM, Donner AP, Trevithick JR: A possible role for vitamins C and E in cataract prevention. Am J Clin Nutr, 1991; 53: 346S-51S.
3. Chylack LT, Jr., Brown NP, Bron A, Hurst M, Kopcke W, Thien U et al: The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 2002; 9: 49-80.
4. Koepcke W, Schalch W, Chylack LT, et al: The influence of vitamin levels and baseline variables on the progression of cataract in the Roche European American Cataract Trial (REACT). Ophthalmic Research, 30 Supplement, 172. 1998. Ref Type: Abstract.
5. Ross WM, Creighton MO, Trevithick JR: Radiation cataractogenesis induced by neutron or gamma irradiation in the rat lens is reduced by vitamin E. Scanning Microsc. 1990; 4: 641-49.
6. West S, Vitale S, Hallfrisch J, Munoz B, Muller D, Bressler S et al: Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol, 1994; 112: 222-27.
7. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med, 1993; 328: 1444-49.
8. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med, 1993; 328: 1450-56.
9. Chylack LT, Jr: Antioxidants and Age-related Cataract- Implications of REACT and AREDS Trial Results For Future Research and Public Health Planning. Ophthalmic Res. 2 A.D. 34: 88.
10. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol, 2001; 119: 1439-52.
11. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age- related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol, 2001; 119: 1417-36.
12. Schalch W, Chylack LT: Antioxidant Micronutrienets and cataract. Review and comparison of the AREDS and REACT cataract studies. Ophthalmologe, 2003; 100: 181-89.
13. Statistics Canada. Population Projections for Canada, Provinces and Territories, 2000-2026. 2000. Ottawa, Ontario, Statistics Canada. Ref Type: Serial (Book, Monograph)
14. U.S. Bureau of the Census. Statistical Abstract of the United States 1993. 113(Projection 2). 1993. Washington, D.C., U.S. Bureau of the Census. Ref Type: Serial (Book,Monograph)
15. Gailitis M: Ontario Cataract Operations Broken Down by Age and Sex. 1996. Ref Type: Personal Communication
16. Management of functional impairment due to cataract in adults. Cataract Management Guideline Panel. Ophthalmology, 1993; 100: 1S-350S.
17. Trevithick JR, Mitton KP: Vitamins C and E in cataract risk reduction. Int Ophthalmol Clin, 2000; 40: 59-69.
18. Lydahl E: Secondary cataract incidence percent. 1996. Ref Type: Personal Communication
19. Kahn HA, Leibowitz HM, Ganley JP, et al: The Framingham Eye Study 1. Outline and major prevalence findings. Am J Epidemiol, 1977; 106: 17-32.
20. Liebowitz H.M, Kreuger D E, Maunder LR, et al. The Framingham Study Monograph. Survey of Ophthalmology 24 (Supplement), 1980: 335-610.
21. Robertson JM, Donner AP, Trevithick JR. A possible role for vitamins C and E in cataract prevention. Am J Clin Nutr, 1991; 53: 346S-51S.
22. Trevithick JR, Mitton KP: Vitamins C and E in cataract risk reduction. Int Ophthalmol Clin, 2000; 40: 59-69.
23. Schalch W, Chylack LT: [Antioxidant micronutrients and cataract.Review and comparison of the AREDS and REACT cataract studies]. Ophthalmologe, 2003; 100: 181-89.
24. Lipscomb J, Weinstein MC, Torrance GW: Time Preference, In: eds. Gold M, Siegel J, Russell L. Cost Effectiveness in Health and Medicine. Oxford. England: Oxford University Press; 1996. 214-46.
25. Packer L: Protective role of vitamin E in biological systems. Am J Clin Nutr, 1991; 53: 1050S-5S.
26. Packer L, Landvik S: Vitamin E in biological systems. Adv Exp Med Biol. 1990: 264: 93-103.
27. Galli F, Stabile AM, Betti M, Conte C, Pistilli A, Rende M et al: The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation. Arch Biochem Biophys, 2004; 423: 97-102.
28. Azzi A, Davies KJ, Kelly F: Free radical biology - terminology and critical thinking. FEBS Lett. 2004; 558: 3-6.
29. Azzi A, Gysin R, Kempna P, Ricciarelli R, Villacorta L, Visarius T et al: The role of alpha-tocopherol in preventing disease: from epidemiology to molecular events. Mol Aspects Med, 2003; 24: 325-36.
30. Kilic F, Trevithick JR: Modelling cortical cataractogenesis. XXIX. Calpain proteolysis of lens fodrin in cataract. Biochem Mol Biol Int, 1998; 45: 963-78.
31. Niki E, Noguchi N, Tsuchihashi H, Gotoh N: Interaction among vitamin C, vitamin E, and beta-carotene. Am J Clin Nutr, 1995; 62: 1322S-6S.
32. Laupacis A, Feeny D, Detsky AS, Tugwell PX: Tentative guidelines for using clinical and economic evaluations revisited. Can Med Assoc J, 1993; 148: 927-29.